Drug Shortage Report for PANTOPRAZOLE SODIUM FOR INJECTION

Last updated on 2021-04-23 History
Report ID 86240
Drug Identification Number 02441527
Brand name PANTOPRAZOLE SODIUM FOR INJECTION
Common or Proper name Pantoprazole for Injection
Company Name GENERIC MEDICAL PARTNERS INC
Market Status MARKETED
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 Vial
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-06-11
Actual start date 2019-06-11
Estimated end date
Actual end date 2021-01-01
Shortage status Resolved
Updated date 2021-04-23
Company comments GMP will make Pantoprazole 40 mg available to supply contract or specific volume demand. Please contact GMP in this respect.
Health Canada comments
Tier 3 Status No
Contact Address 1500 DON MILLS ROAD, SUITE 711
TORONTO, ONTARIO
CANADA M3B 3K4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-04-23 French Compare
v6 2021-04-23 English Compare
v5 2021-04-23 English Compare
v4 2021-04-23 English Compare
v3 2019-06-12 English Compare
v2 2019-06-11 French Compare
v1 2019-06-11 English Compare

Showing 1 to 7 of 7